In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

New data from Biogen reveals higher Spinraza doses may enhance motor function in SMA patients. Read more here.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...

A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and ...

New guidelines from the American College of Cardiology and American Heart Association update best practices for managing peripheral artery disease (PAD). The comprehensive clinical guidelines synopsis ...

A single dose of a synthetic, proprietary formulation of psilocybin (COMP360) was found to improve symptoms in patients with treatment-resistant ...